These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 22409564

  • 1. Mycophenolate mofetil in the treatment of chronic non-infectious, non-necrotizing scleritis.
    Kolomeyer AM, Ragam A, Shah K, Jachens AW, Tu Y, Chu DS.
    Ocul Immunol Inflamm; 2012 Apr; 20(2):113-8. PubMed ID: 22409564
    [Abstract] [Full Text] [Related]

  • 2. Mycophenolate mofetil for the treatment of scleritis.
    Sen HN, Suhler EB, Al-Khatib SQ, Djalilian AR, Nussenblatt RB, Buggage RR.
    Ophthalmology; 2003 Sep; 110(9):1750-5. PubMed ID: 13129873
    [Abstract] [Full Text] [Related]

  • 3. Mycophenolate mofetil after methotrexate failure or intolerance in the treatment of scleritis and uveitis.
    Sobrin L, Christen W, Foster CS.
    Ophthalmology; 2008 Aug; 115(8):1416-21, 1421.e1. PubMed ID: 18221998
    [Abstract] [Full Text] [Related]

  • 4. Mycophenolate mofetil therapy for inflammatory eye disease.
    Thorne JE, Jabs DA, Qazi FA, Nguyen QD, Kempen JH, Dunn JP.
    Ophthalmology; 2005 Aug; 112(8):1472-7. PubMed ID: 16061096
    [Abstract] [Full Text] [Related]

  • 5. Retrospective review of methotrexate therapy in the treatment of chronic, noninfectious, nonnecrotizing scleritis.
    Jachens AW, Chu DS.
    Am J Ophthalmol; 2008 Mar; 145(3):487-492. PubMed ID: 18282493
    [Abstract] [Full Text] [Related]

  • 6. Visual outcome, treatment results, and prognostic factors in patients with scleritis.
    Wieringa WG, Wieringa JE, ten Dam-van Loon NH, Los LI.
    Ophthalmology; 2013 Feb; 120(2):379-86. PubMed ID: 23177360
    [Abstract] [Full Text] [Related]

  • 7. Cyclo-oxygenase inhibitors in the treatment of chronic non-infectious, non-necrotizing scleritis and episcleritis.
    Kolomeyer AM, Ragam A, Shah K, Do BK, Shah VP, Chu DS.
    Ocul Immunol Inflamm; 2012 Aug; 20(4):293-9. PubMed ID: 22642498
    [Abstract] [Full Text] [Related]

  • 8. Mycophenolate mofetil in the treatment of uveitis in children.
    Doycheva D, Deuter C, Stuebiger N, Biester S, Zierhut M.
    Br J Ophthalmol; 2007 Feb; 91(2):180-4. PubMed ID: 16825275
    [Abstract] [Full Text] [Related]

  • 9. Mycophenolate mofetil for ocular inflammation.
    Daniel E, Thorne JE, Newcomb CW, Pujari SS, Kaçmaz RO, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Suhler EB, Foster CS, Jabs DA, Kempen JH.
    Am J Ophthalmol; 2010 Mar; 149(3):423-32.e1-2. PubMed ID: 20042178
    [Abstract] [Full Text] [Related]

  • 10. Mycophenolate Mofetil Therapy in Refractory Inflammatory Eye Disease.
    Cuchacovich M, Solanes F, Perez C, Verdaguer JI, Verdaguer J, Castiglione E, Carpentier C, Traipe L, Villarroel F.
    J Ocul Pharmacol Ther; 2016 Mar; 32(1):55-61. PubMed ID: 26562247
    [Abstract] [Full Text] [Related]

  • 11. Long-term results of therapy with mycophenolate mofetil in chronic non-infectious uveitis.
    Doycheva D, Zierhut M, Blumenstock G, Stuebiger N, Deuter C.
    Graefes Arch Clin Exp Ophthalmol; 2011 Aug; 249(8):1235-43. PubMed ID: 21720813
    [Abstract] [Full Text] [Related]

  • 12. Treatment of mucous membrane pemphigoid with mycophenolate mofetil.
    Nottage JM, Hammersmith KM, Murchison AP, Felipe AF, Penne R, Raber I.
    Cornea; 2013 Jun; 32(6):810-5. PubMed ID: 23132447
    [Abstract] [Full Text] [Related]

  • 13. Mycophenolate mofetil is a highly effective and safe immunosuppressive agent for the treatment of uveitis : a retrospective analysis of 106 patients.
    Siepmann K, Huber M, Stübiger N, Deuter C, Zierhut M.
    Graefes Arch Clin Exp Ophthalmol; 2006 Jul; 244(7):788-94. PubMed ID: 16163494
    [Abstract] [Full Text] [Related]

  • 14. Enteric-coated mycophenolate sodium as a corticosteroid-sparing agent for the treatment of autoimmune scleritis.
    Hwang YS, Chen HC, Chen KJ, Lai CC, Yeung L, Yang KJ, Lin KK, Hsiao CH.
    Cornea; 2011 Mar; 30(3):260-4. PubMed ID: 21099416
    [Abstract] [Full Text] [Related]

  • 15. Mycophenolate mofetil. A useful immunosuppressive in inflammatory eye disease.
    Larkin G, Lightman S.
    Ophthalmology; 1999 Feb; 106(2):370-4. PubMed ID: 9951492
    [Abstract] [Full Text] [Related]

  • 16. Tolerability of mycophenolate mofetil in patients with systemic lupus erythematosus.
    Riskalla MM, Somers EC, Fatica RA, McCune WJ.
    J Rheumatol; 2003 Jul; 30(7):1508-12. PubMed ID: 12858449
    [Abstract] [Full Text] [Related]

  • 17. Mycophenolate mofetil as an immunosuppressive agent in refractory inflammatory eye disease.
    Choudhary A, Harding SP, Bucknall RC, Pearce IA.
    J Ocul Pharmacol Ther; 2006 Jun; 22(3):168-75. PubMed ID: 16808677
    [Abstract] [Full Text] [Related]

  • 18. Treatment of chronic, noninfectious, nonnecrotizing scleritis with tumor necrosis factor alpha inhibitors.
    Ragam A, Kolomeyer AM, Fang C, Xu Y, Chu DS.
    Ocul Immunol Inflamm; 2014 Dec; 22(6):469-77. PubMed ID: 24354512
    [Abstract] [Full Text] [Related]

  • 19. Mycophenolate mofetil monotherapy in the management of paediatric uveitis.
    Chang PY, Giuliari GP, Shaikh M, Thakuria P, Makhoul D, Foster CS.
    Eye (Lond); 2011 Apr; 25(4):427-35. PubMed ID: 21423146
    [Abstract] [Full Text] [Related]

  • 20. Comparison Between Methotrexate and Mycophenolate Mofetil Monotherapy for the Control of Noninfectious Ocular Inflammatory Diseases.
    Gangaputra SS, Newcomb CW, Joffe MM, Dreger K, Begum H, Artornsombudh P, Pujari SS, Daniel E, Sen HN, Suhler EB, Thorne JE, Bhatt NP, Foster CS, Jabs DA, Nussenblatt RB, Rosenbaum JT, Levy-Clarke GA, Kempen JH, SITE Cohort Research Group.
    Am J Ophthalmol; 2019 Dec; 208():68-75. PubMed ID: 31344346
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.